X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2602) 2602
Book Chapter (128) 128
Book / eBook (20) 20
Publication (17) 17
Dissertation (2) 2
Streaming Video (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1554) 1554
life sciences & biomedicine (1532) 1532
humans (1375) 1375
antithrombotic therapy (1034) 1034
male (725) 725
cardiovascular system & cardiology (702) 702
female (599) 599
fibrinolytic agents - therapeutic use (487) 487
aged (475) 475
anticoagulants (474) 474
atrial fibrillation (459) 459
antithrombotic (430) 430
cardiac & cardiovascular systems (420) 420
risk factors (408) 408
middle aged (385) 385
anticoagulants - therapeutic use (377) 377
animals (365) 365
peripheral vascular disease (347) 347
pharmacology & pharmacy (326) 326
thrombosis (317) 317
stroke (310) 310
hematology (290) 290
antithrombotics (279) 279
treatment outcome (276) 276
platelet aggregation inhibitors - therapeutic use (256) 256
aged, 80 and over (254) 254
medicine & public health (241) 241
aspirin (236) 236
fibrinolytic agents - adverse effects (232) 232
antithrombotic agents (208) 208
thrombosis - drug therapy (206) 206
bleeding (200) 200
cardiology (195) 195
warfarin (191) 191
thromboembolism (189) 189
retrospective studies (186) 186
fibrinolytic agents - administration & dosage (179) 179
anticoagulants - adverse effects (176) 176
atrial fibrillation - drug therapy (176) 176
anticoagulants - administration & dosage (172) 172
hemorrhage - chemically induced (172) 172
stroke - prevention & control (169) 169
adult (166) 166
care and treatment (165) 165
fibrinolytic agents - pharmacology (164) 164
surgery (160) 160
general & internal medicine (159) 159
anticoagulation (155) 155
abridged index medicus (152) 152
antiplatelet (148) 148
acute coronary syndrome (147) 147
drug therapy, combination (147) 147
risk assessment (147) 147
thrombosis - prevention & control (146) 146
platelet aggregation inhibitors - adverse effects (145) 145
antithrombotic treatment (144) 144
percutaneous coronary intervention (143) 143
neurosciences & neurology (142) 142
analysis (141) 141
rats (141) 141
administration, oral (136) 136
internal medicine (134) 134
aspirin - therapeutic use (131) 131
atrial fibrillation - complications (131) 131
mortality (124) 124
clinical neurology (123) 123
dose-response relationship, drug (123) 123
heparin (121) 121
anticoagulant (120) 120
prevention (119) 119
platelet aggregation inhibitors - administration & dosage (118) 118
platelet aggregation - drug effects (117) 117
drug therapy (115) 115
blood coagulation - drug effects (113) 113
time factors (110) 110
antithrombotic drugs (107) 107
clopidogrel (107) 107
stroke - etiology (106) 106
cardiovascular diseases (104) 104
myocardial infarction (100) 100
anticoagulants - pharmacology (98) 98
cardiovascular (98) 98
medicine, general & internal (97) 97
disease models, animal (96) 96
hemorrhage (96) 96
factor xa inhibitors (92) 92
research (92) 92
coronary heart disease (91) 91
platelet aggregation inhibitors - pharmacology (91) 91
acute coronary syndromes (89) 89
antiplatelet therapy (89) 89
health aspects (89) 89
practice guidelines as topic (88) 88
randomized controlled trials as topic (88) 88
heparin - therapeutic use (87) 87
incidence (87) 87
cardiovascular agents (84) 84
prospective studies (84) 84
thrombin (83) 83
thromboembolism - prevention & control (83) 83
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2545) 2545
Japanese (81) 81
German (79) 79
Russian (53) 53
Spanish (36) 36
French (32) 32
Portuguese (15) 15
Korean (11) 11
Italian (9) 9
Czech (8) 8
Chinese (4) 4
Hungarian (3) 3
Polish (3) 3
Dutch (2) 2
Turkish (2) 2
Arabic (1) 1
Danish (1) 1
Norwegian (1) 1
Slovak (1) 1
Slovenian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e669S - e690S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods... 
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e44S - e88S
Background: The objective of this article is to summarize the published literature concerning the pharmacokinetics and pharmacodynamics of oral anticoagulant... 
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | United States | Humans | Pyridines - pharmacokinetics | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacokinetics | Dose-Response Relationship, Drug | Rivaroxaban | Pyridines - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Benzimidazoles - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Benzimidazoles - adverse effects | Morpholines - adverse effects | Pyridines - administration & dosage | Administration, Oral | Morpholines - administration & dosage | Benzimidazoles - pharmacokinetics | Anticoagulants - adverse effects | Evidence-Based Medicine | Factor Xa - metabolism | Thiophenes - pharmacokinetics | Vitamin K - blood | Antithrombins - adverse effects | Anticoagulants - pharmacokinetics | Thrombosis - drug therapy | Morpholines - pharmacokinetics | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e326S - e350S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2 Suppl, pp. e691S - e736S
Journal Article